# Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

> **NCT05955924** · PHASE3 · RECRUITING · sponsor: **Women's College Hospital** · enrollment: 396 (estimated)

## Conditions studied

- Non-melanoma Skin Cancer
- Carcinoma, Squamous Cell
- Carcinoma, Basal Cell
- Keratinocyte Carcinoma

## Interventions

- **DRUG:** Nicotinamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05955924
- **Lead sponsor:** Women's College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-28
- **Primary completion:** 2027-08
- **Final completion:** 2027-08
- **Target enrollment:** 396 (ESTIMATED)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05955924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05955924, "Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05955924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*